-
公开(公告)号:EP1797878A2
公开(公告)日:2007-06-20
申请号:EP07003532.4
申请日:2001-06-08
IPC分类号: A61K31/422 , A61K31/423 , A61K31/444 , A61K31/4439 , A61K31/455 , A61K31/541 , A61K31/5513 , C07D277/82 , C07D417/12 , C07D417/14 , A61P25/00 , A61P25/16 , A61P25/28 , A61P9/00 , A61P13/12 , A61P3/10 , A61P11/06
CPC分类号: C07D417/04 , A61K31/427 , A61K31/428 , A61K31/4439 , A61K31/444 , A61K31/455 , A61K31/5375 , A61K31/541 , A61K31/5513 , C07D277/82 , C07D417/12 , C07D417/14
摘要: The present invention relates to compounds of the general formula
and to their pharmaceutically acceptable salts for the treatment of diseases related to the adenosine receptor.-
公开(公告)号:EP1797878A3
公开(公告)日:2010-01-20
申请号:EP07003532.4
申请日:2001-06-08
IPC分类号: A61K31/422 , A61K31/423 , A61K31/444 , A61K31/4439 , A61K31/455 , A61K31/541 , A61K31/5513 , C07D277/82 , C07D417/12 , C07D417/14 , A61P25/00 , A61P25/16 , A61P25/28 , A61P9/00 , A61P13/12 , A61P3/10 , A61P11/06
CPC分类号: C07D417/04 , A61K31/427 , A61K31/428 , A61K31/4439 , A61K31/444 , A61K31/455 , A61K31/5375 , A61K31/541 , A61K31/5513 , C07D277/82 , C07D417/12 , C07D417/14
摘要: The present invention relates to compounds of the general formula
and to their pharmaceutically acceptable salts for the treatment of diseases related to the adenosine receptor.摘要翻译: 本发明涉及通式化合物及其药学上可接受的盐,用于治疗与腺苷受体有关的疾病。
-